Literature DB >> 25370733

MicroRNA-146a rs2910164 polymorphism and the risk of diffuse large B cell lymphoma in the Chinese Han population.

Haifeng Zhuang1, Jianping Shen, Zhiyin Zheng, Xiusu Luo, Ruilan Gao, Xiaofen Zhuang.   

Abstract

The aim of this study was to determine the association of the microRNA-146a (miR-146a) polymorphism with the risk of diffuse large B cell lymphoma (DLBCL). The genotyping of miR-146a rs2910164 polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The results showed that CC genotype and C alleles distribution in the DLBCL patient was significantly higher than that of the controls (p = 0.01 and p = 0.01, respectively). No significant differences were found between the two subgroups when stratified by clinical characteristics including sexual, age at admission, performance status, pathological type, Ann Arbor stage, LDH and β2-MG value. The miR-146a expression was detected by the Taqman real-time PCR. The result showed that the miR-146a expression was notably upregulated in DLBCL patients when compared with controls (p = 0.02). In addition, the miR-146a expression of CC genotypes subgroup was drastically downregulated than that of GC/GG genotype subgroup in DLBCL patients (p = 0.0003), suggesting that this polymorphism can functionally affect the expression of miR-146a. In conclusion, it was shown that the miR-146a rs2910164 polymorphism is associated with the risk of DLBCL in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370733     DOI: 10.1007/s12032-014-0306-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  13 in total

1.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.

Authors:  Teng Xu; Ying Zhu; Qing-Kun Wei; Yunfei Yuan; Fan Zhou; Yi-Yuan Ge; Jian-Rong Yang; Hang Su; Shi-Mei Zhuang
Journal:  Carcinogenesis       Date:  2008-08-18       Impact factor: 4.944

Review 2.  [Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues].

Authors:  Masao Tomonaga
Journal:  Rinsho Ketsueki       Date:  2009-10

3.  No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.

Authors:  Hikmet Akkız; Süleyman Bayram; Aynur Bekar; Ersin Akgöllü; Oğuz Usküdar; Macit Sandıkçı
Journal:  Gene       Date:  2011-07-23       Impact factor: 3.688

4.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

5.  The association between common genetic variant of microRNA-146a and cancer susceptibility.

Authors:  Li-Xin Qiu; Jing He; Meng-Yun Wang; Ruo-Xin Zhang; Ting-Yan Shi; Mei-Ling Zhu; Chen Mao; Si Sun; Fang-Fang Lv; Chun-Lei Zheng; Xiao-Dong Zhu
Journal:  Cytokine       Date:  2011-10-05       Impact factor: 3.861

Review 6.  Common gene polymorphisms, cancer progression and prognosis.

Authors:  Alexandre Loktionov
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population.

Authors:  Hyo-Sung Jeon; Yong Hoon Lee; Shin Yup Lee; Ji-Ae Jang; Yi-Young Choi; Seung Soo Yoo; Won Kee Lee; Jin Eun Choi; Ji Woong Son; Young Mo Kang; Jae Yong Park
Journal:  Gene       Date:  2013-10-19       Impact factor: 3.688

9.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.

Authors:  Krystian Jazdzewski; Sandya Liyanarachchi; Michal Swierniak; Janusz Pachucki; Matthew D Ringel; Barbara Jarzab; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma.

Authors:  S Caramuta; L Lee; D M Ozata; P Akçakaya; P Georgii-Hemming; H Xie; R-M Amini; C H Lawrie; G Enblad; C Larsson; M Berglund; W-O Lui
Journal:  Blood Cancer J       Date:  2013-10-11       Impact factor: 11.037

View more
  9 in total

1.  The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms.

Authors:  Somayeh Yazdanparast; Zoufang Huang; Shayan Keramat; Mehrdad Izadirad; Yi-Dong Li; Letao Bo; Ahmad Gharehbaghian; Zhe-Sheng Chen
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

2.  The Influence of Interleukin-2 Gene Polymorphisms on the Risk and Clinical Outcome of Non-Hodgkin Lymphoma.

Authors:  Somaia Mohammed Mousa; Manal Mohamed Makhlouf; Ekhlass Talaat Mohammed; Hamdy Mohamed Zawam
Journal:  Indian J Hematol Blood Transfus       Date:  2021-01-04       Impact factor: 0.915

Review 3.  Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.

Authors:  Gabrielle Bradshaw; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

4.  The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma.

Authors:  Nasrin Zare; Nahid Eskandari; Valiollah Mehrzad; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2019-02-25       Impact factor: 1.852

Review 5.  Exosomal MiRNAs in Pediatric Cancers.

Authors:  Angela Galardi; Marta Colletti; Virginia Di Paolo; Patrizia Vitullo; Loretta Antonetti; Ida Russo; Angela Di Giannatale
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

Review 6.  Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.

Authors:  Yan Shi; Daihong Ding; Rongfeng Qu; Yan Tang; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2020-11-24       Impact factor: 4.147

7.  High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.

Authors:  Teruumi Minezaki; Yoshihiko Usui; Masaki Asakage; Masakatsu Takanashi; Hiroyuki Shimizu; Naoya Nezu; Akitomo Narimatsu; Kinya Tsubota; Kazuhiko Umazume; Naoyuki Yamakawa; Masahiko Kuroda; Hiroshi Goto
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

8.  miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Xinyuan Wang; Yutian Kan; Leiyuan Chen; Peng Ge; Tingting Ding; Qiongli Zhai; Yong Yu; Xiaofang Wang; Zhigang Zhao; Hongliang Yang; Xianming Liu; Lanfang Li; Lihua Qiu; Zhengzi Qian; Huilai Zhang; Yafei Wang; Haifeng Zhao
Journal:  Oncol Lett       Date:  2020-03-10       Impact factor: 2.967

9.  Pre-miR-27a rs895819 polymorphism and risk of diffuse large B-cell lymphoma.

Authors:  Weiyan Tang; Haonan Xu; Dawei Ma; Rong Ma; Jianqiu Wu; Xinnian Yu; Jifeng Feng; Qizhan Liu
Journal:  J Clin Lab Anal       Date:  2019-12-03       Impact factor: 3.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.